Cargando…
Feasibility of Applying Helper-Dependent Adenoviral Vectors for Cancer Immunotherapy
Adenoviruses (Ads) infect a broad range of tissue types, and derived vectors have been extensively used for gene therapy. Helper-dependent Ad vectors (HDAds), devoid of viral coding sequences, allow for insertion of large or multiple transgenes in a single vector and have been preclinically used for...
Autores principales: | Farzad, Lisa M., Suzuki, Masataka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423480/ https://www.ncbi.nlm.nih.gov/pubmed/28548063 http://dx.doi.org/10.3390/biomedicines2010110 |
Ejemplares similares
-
Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy
por: Farzad, Lisa, et al.
Publicado: (2014) -
Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy
por: Piccolo, Pasquale, et al.
Publicado: (2014) -
Gene Therapy with Helper-Dependent Adenoviral Vectors: Current Advances and Future Perspectives
por: Vetrini, Francesco, et al.
Publicado: (2010) -
Subretinal gene delivery using helper-dependent adenoviral vectors
por: Wu, Linda, et al.
Publicado: (2011) -
Immunology of Adenoviral Vectors in Cancer Therapy
por: Shaw, Amanda Rosewell, et al.
Publicado: (2019)